Therapeutic Applications of Iminosugars: Current Perspectives and Future Opportunities

https://doi.org/10.1016/B978-0-12-381290-2.00004-5Get rights and content

Publisher Summary

The understanding of the role of carbohydrates, their receptors, and their handling processes in the functioning of biological systems is an area in which major advances have been made during the past 20 years. The diverse structures displayed by carbohydrates provide a substantial opportunity for the identification of new chemotherapeutic targets and the development of new therapies. This has motivated both synthetic and medicinal chemists in the pursuit of new medicines although carbohydrates themselves can rarely be employed for this purpose owing to their metabolic instability and rapid degradation in vivo. As a consequence, researchers have focused on the design and synthesis of carbohydrate mimetics with greater stability, affinity, and efficacy. Iminosugars are the most attractive class of carbohydrate mimetics reported to date and are ideally positioned to take advantage of the increasing understanding of this area. The chapter summarizes the status of the iminosugar field providing an overview of the classification, occurrence, and synthesis of iminosugars, before discussing in detail the therapeutic potential of this class of molecule.

Section snippets

INTRODUCTION

Our understanding of the role of carbohydrates, their receptors and their handling processes in the functioning of biological systems is an area in which major advances have been made during the past 20 years. The diverse structures displayed by carbohydrates provide a substantial opportunity for the identification of new chemotherapeutic targets and the development of new therapies. This has motivated both synthetic and medicinal chemists, in the pursuit of new medicines although carbohydrates

IMINOSUGARS – CLASSIFICATION, OCCURRENCE AND HISTORICAL CONTEXT

Iminosugars are small organic compounds which mimic monosaccharides or their hydrolysis transition state equivalents but contain a nitrogen atom in place of the endocyclic oxygen, and as such fall under the definition of the polyhydroxylated alkaloids. The iminosugar motif can be recognized across many common compound classes including monocyclic and bicyclic templates. While the synthetic analogues may be represented by numerous ring forms, the naturally occurring iminosugars are classified

ADVANTAGEOUS PROPERTIES OF IMINOSUGARS

Iminosugars have a number of intrinsic properties which are positive attributes as potential drug candidates. The problem of the water solubility of lead molecules has occupied a prominent place in medicinal chemistry with many potent classical small molecules suffering from marginal water solubility. Enormous resources have been deployed to address this issue both in medicinal chemistry and in formulation. No such problem burdens the iminosugar field where adequate water solubility is a key

APPROACHES TO THE SYNTHESIS OF IMINOSUGARS

Despite the initial promise shown by these early compounds, to date, as a therapeutic class, iminosugars have failed to realize their full commercial potential. A number of chemical characteristics have impeded the rate of development and exploitation within the pharmaceutical and biotech sectors and this has undoubtedly restricted the level to which the iminosugar field has been explored by industry to date. The molecules are chirally complex, generally highly polar and generally lack a

THERAPEUTIC APPLICATIONS OF IMINOSUGARS

As would be expected for a series of polyhydroxylated glycomimetics, iminosugars have historically been of interest for their biological activity in modulating the action of carbohydrate processing enzymes and many therapeutic opportunities arise from targeting these processes [54], [55], [56], [57], [58]. The full impact of the pioneering work in exploring the importance of glycobiology is becoming increasingly apparent [59], [60], [61] with an array of new targets across different therapeutic

OUTLOOK AND FUTURE OPPORTUNITIES

The full impact of the pioneering work of Dwek, Varki and others in realizing the importance of glycobiology in health and disease is becoming increasingly apparent [59], [60], [61], [62], [63], [64], [65], [66]. The number of new druggable targets across different therapeutic areas is vast and current efforts have only just started to address what might be possible in the search for new therapeutics. Within each target class there are numerous individual targets encompassing a range of

References (253)

  • B.G. Winchester

    Tetrahedron: Asymmetry

    (2009)
  • L.D. Hohenschutz et al.

    J. Phytochem.

    (1981)
  • R.J. Nash et al.

    Tetrahedron Lett.

    (1988)
  • A. Kato et al.

    Carbohydr. Res.

    (1999)
  • A. Kato et al.

    Phytochemistry

    (2008)
  • K. Nakagawa et al.

    Anal. Biochem.

    (2010)
  • N. Nuengchamnong et al.

    J. Pharm. Biomed. Anal.

    (2007)
  • D. Best et al.

    Tetrahedron: Asymmetry

    (2010)
  • A.C. Weymouth-Wilson et al.

    Tetrahedron Lett.

    (2009)
  • P. Compain et al.

    Tetrahedron: Asymmetry

    (2009)
  • G. Lesma et al.

    Tetrahedron: Asymmetry

    (2007)
  • S.G. Davies et al.

    Tetrahedron: Asymmetry

    (2009)
  • G.S. Jacob

    Curr. Opin. Struct. Biol.

    (1995)
  • K. Ohtsubo et al.

    Cell

    (2006)
  • I.O. Potapenko et al.

    Mol. Oncol.

    (2010)
  • J.Y. Sun et al.

    Phytomedicine

    (2009)
  • C. Galustian et al.

    Immunopharmacology

    (1994)
  • J.W. Dennis et al.

    Biochem. Pharmacol.

    (1993)
  • W.H. Pearson et al.

    Tetrahedron Lett.

    (2001)
  • W.H. Pearson et al.

    Tetrahedron Lett.

    (2001)
  • C. Bello et al.

    Bioorg. Med. Chem.

    (2010)
  • D. D’Alonzo et al.

    Curr. Med. Chem.

    (2009)
  • Horne, G., Wilson, F.X., Tinsley, J., Williams, D.H. and Storer, R. (2010) Drug Discov. Today...
  • M. Berg et al.

    Curr. Med. Chem.

    (2010)
  • T. Donaldson et al.

    Infect. Disord. Drug Targets

    (2010)
  • K. Clinch et al.

    J. Med. Chem.

    (2009)
  • P. Merino et al.

    Curr. Med. Chem.

    (2008)
  • A. Korycka et al.

    Mini Rev. Med. Chem.

    (2007)
  • T. Nishikawa et al.

    J. Antibiotics

    (1965)
  • S. Inouye et al.

    J. Antibiotics

    (1966)
  • N. Ishida et al.

    Antibiotics

    (1967)
  • N. Ishida et al.

    Antibiotics

    (1967)
  • T. Niwa et al.

    J. Antibiotics

    (1984)
  • Y. Miyake et al.

    Antibiotics

    (1987)
  • M. Koyama et al.

    Agric. Biol. Chem.

    (1974)
  • M. Yagi et al.

    Nippon Nogeikagaku Kaishi

    (1976)
  • H. Paulsen et al.

    Chem. Ber.

    (1967)
  • L.E. Fellows et al.

    J. Chem. Soc. Chem. Commun.

    (1979)
  • S.M. Colegate et al.

    Aust. J. Chem.

    (1979)
  • R.J. Molyneux et al.

    J. Nat. Prod.

    (1988)
  • R.J. Nash et al.

    Tetrahedron Lett.

    (1995)
  • D. Tepfer et al.

    J. Bacteriol.

    (1988)
  • J.R. Jacob et al.

    J. Microbiol.

    (2007)
  • N. Asano et al.

    J. Agric. Food Chem.

    (2001)
  • R.H. Lachmann

    Drugs Today (Barc)

    (2006)
  • L. Cipolla et al.

    Curr. Top. Med. Chem.

    (2003)
  • B.L. Stocker et al.

    Eur. J. Org. Chem.

    (2010)
  • L. Cipolla et al.

    Comb. Chem. High Throughput Screen.

    (2006)
  • Cited by (95)

    • The emerging polyhydroxyazepane-based C-glycosides for glycosidase inhibition

      2023, Synthetic Strategies in Carbohydrate Chemistry
    • Recent synthetic strategies to access diverse iminosugars

      2023, Synthetic Strategies in Carbohydrate Chemistry
    • Design, synthesis, and preliminary immunopotentiating activity of new analogues of nojirimycin

      2022, Carbohydrate Research
      Citation Excerpt :

      Plant and microbial iminosugars confer numerous therapeutic benefits due to their glycosidase inhibitory activity, which led to widespread efforts to develop synthetic analogues of iminosugar nojirimycin (Fig. 1) [1,2].

    • One-pot strategy: A highly economical tool in organic synthesis and medicinal chemistry

      2020, Green Approaches in Medicinal Chemistry for Sustainable Drug Design
    View all citing articles on Scopus
    View full text